I'm pleased to share my recent first-author work in the @MichaelNADbio Lab published recently in @CellChemBiol describing a selective PARP7 inhibitor, KMR-206.
A short thread on our findings below:
https://t.co/ME1jXWyG47
On 2/26, I am excited to be running the Disney Princess Half Marathon on #TeamKesem. My goal is to raise $1500 for @CampKesem , a nonprofit that supports children through and beyond a parent's cancer.
You can support, share + learn more on my page: https://t.co/J2gmg5TDIv
(7/7) Finally, like most work in our lab, this was a collaborative effort and I would like to thank our collaborators and current and past members of the Cohen lab. @kelsiemrod, @dannybejan, @ivansiord, @SchultzLabOHSU and many others not on twitter
I'm pleased to share my recent first-author work in the @MichaelNADbio Lab published recently in @CellChemBiol describing a selective PARP7 inhibitor, KMR-206.
A short thread on our findings below:
https://t.co/ME1jXWyG47
(6/7) While these results are only correlative, we believe it highlights the utility of having structurally distinct probes for studying mechanism of action. For more on this, PARP7's roles in IFN-I regulation, and KMR-206, check out the full paper!
Hi all, I’d like to officially announce I’m on the job hunt! I’m looking for a Scientist or higher level industry position in the medicinal chemistry/drug discovery space located in the greater Los Angeles area (for family reasons) or remote.
resume -> https://t.co/z4jn65CHaH
The QBI Online Seminar Series will feature Michael Cohen @MichaelNADbio, Assistant Professor in the Department of Chemical Physiology and Biochemistry @OHSUNews on 02/09 at 11 AM PT! Learn more about his work & register for his talk: https://t.co/AebvS8UBWA
In this long summer before starting my #PhD program in neuroscience, I am envisioning what I want my skill set and CV to look like in 4-5 years. #AcademicChatter#AcademicTwitter what are some goals that you have set for yourself or your students who are studying PhDs?